Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol sustained-release capsules in mild to moderate primary hypertension
CTR20131916Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carvedilol in essential hypertension, sponsored by Hengrui Therapeutics. Started Jan 2014; status: completed.
02
Drugs
carvedilol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20131916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131916.